Filing Details
- Accession Number:
- 0000899243-19-022786
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-04 21:42:42
- Reporting Period:
- 2019-08-30
- Accepted Time:
- 2019-09-04 21:42:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1241357 | I Jean Liu | 21823 30Th Drive Se Bothell WA 98021 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-08-30 | 18,995 | $0.00 | 79,899 | No | 4 | A | Direct | |
Common Stock | Disposition | 2019-09-03 | 1,779 | $0.00 | 78,120 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Options (right to buy) | Acquisiton | 2019-08-30 | 1,333 | $0.00 | 1,333 | $72.64 |
Common Stock | Non. Qualified Stock Option (right to buy) | Acquisiton | 2019-08-30 | 43,786 | $0.00 | 43,786 | $72.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,333 | 2029-08-30 | No | 4 | A | Direct | |
43,786 | 2029-08-30 | No | 4 | A | Direct |
Footnotes
- These shares represent restricted stock units and will be settled in common stock upon vesting.
- Shares shall vest at a rate of 25% on each anniversary of the grant date until all shares are fully vested four years from the grant date.
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- Options shall vest at a rate of 25% one year from grant date and monthly thereafter until all shares are fully vested four years from grant date.